David D. Bushart
Neuroscience · The Ohio State University
Publications
22
Citations
520
Est. group size
—
Recurring co-author estimate
Active years
14
Publishing since 2011
David D. Bushart studies spinocerebellar ataxias, a group of inherited disorders that damage neurons in the cerebellum (a brain region controlling balance and coordination). His work focuses on how malfunctioning ion channels (proteins that control electrical signaling in neurons) and altered neuron excitability contribute to cell degeneration, and he explores potential treatments including antisense oligonucleotide therapy (a gene-targeting drug approach) and channel-modulating drugs. Prospective students would engage with research spanning molecular neuroscience, stem cell models, and translational approaches to neurodegenerative movement disorders.
Publication output peaked between 2018-2020 with several papers per year but has slowed considerably since 2021, averaging about 1 publication per year over the last 5 years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Increased intrinsic membrane excitability is associated with olivary hypertrophy in spinocerebellar ataxia type 1
Human Molecular Genetics · 2024
- Increased intrinsic membrane excitability is associated with hypertrophic olivary degeneration in spinocerebellar ataxia type 1
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke
Translational Stroke Research · 2022
- Preliminary Study of Vibrotactile Feedback during Home-Based Balance and Coordination Training in Individuals with Cerebellar Ataxia
Sensors · 2022
- Vulnerability of Human Cerebellar Neurons to Degeneration in Ataxia-Causing Channelopathies
Frontiers in Systems Neuroscience · 2022
- A Chlorzoxazone‐Baclofen Combination Improves Cerebellar Impairment in Spinocerebellar Ataxia Type 1
Movement Disorders · 2020
- Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1
Human Molecular Genetics · 2020
- Antisense Oligonucleotide Therapy Targeted Against ATXN3 Improves Potassium Channel–Mediated Purkinje Neuron Dysfunction in Spinocerebellar Ataxia Type 3
The Cerebellum · 2020
- A chlorzoxazone-baclofen combination improves cerebellar impairment in spinocerebellar ataxia type 1
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in Spinocerebellar ataxia type 1
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- Augmenting BK Channel Function as Therapy for Spinocerebellar Ataxia (SCA) (5571)
Neurology · 2020
- Nicotinamide Pathway-Dependent Sirt1 Activation Restores Calcium Homeostasis to Achieve Neuroprotection in Spinocerebellar Ataxia Type 7
Neuron · 2019
- Antisense oligonucleotide therapy rescues aggresome formation in a novel spinocerebellar ataxia type 3 human embryonic stem cell line
Stem Cell Research · 2019
- Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases
BMC Medicine · 2019
- Antisense oligonucleotide therapy rescues aggresome formation in a novel Spinocerebellar Ataxia type 3 human embryonic stem cell line
bioRxiv (Cold Spring Harbor Laboratory) · 2019
- bioRxiv (Cold Spring Harbor Laboratory)×4
- Human Molecular Genetics×2
- Neuron×1
- Translational Stroke Research×1
- Neuroscience Letters×1
- Quetzalli D. Angeles-López
Neuroscience · The Ohio State University
- Jing Yang
Neuroscience · Indiana University
- Haoran Huang
Neuroscience · The Ohio State University
- Sandra K. Kostyk
Neuroscience · The Ohio State University
- Chad Hoyle
Neuroscience · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile